Patent · US Active

Implantable devices coated with insulin-mimetic vanadium compounds and methods thereof

US9144633B2 · kind B2 · utility

3Cited by
6References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 9, 2011
Grant dateSep 29, 2015
Priority date
Expiry dateDec 29, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2430/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention discloses vanadium-based insulin-mimetic agent composite coatings, application of these coatings onto implantable devices, and use of the implantable devices for accelerating osseous healing. The invention also encompasses methods of manufacturing implantable devices coated with vanadium-based insulin-mimetic agent composite coatings and the implantable devices so manufactured. The implantable devices have wide applications, including but not limited to treating bone fracture, bone trauma, arthrodesis, and other bone deficit conditions, as well as bone injuries incurred in military and sports activities.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.